The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear¥698.04Fair value¥2,759.90Bull¥5,821.36
FairClose
52-week traded range
52W low ¥2,665.0052W high ¥3,435.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
RIKEN VITAMIN CO.,LTD. closed at ¥3,310.00, 19.9% above the consensus fair value of ¥2,759.90 drawn from 9 valuation models.
Financial DNA score 68/100 — Strong. P/E of 13.9x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
¥698.04
-78.9%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
¥3,910.55
+18.1%
√(22.5 × EPS × BVPS)
EPS=238.19, BVPS=2853.45
P/E Fair Value
¥4,763.80
+43.9%
EPS × 20x (sector P/E)
EPS=238.19, Sector P/E=20x
Peter Lynch (PEG)
¥5,821.36
+75.9%
EPS × Growth% (PEG = 1 is fair)
EPS=238.19, g=24.4%
EV/EBITDA
¥3,677.94
+11.1%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=11.58B
Dividend Discount (DDM)
¥1,401.12
-57.7%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=109.89, r=10%, g=2%
Book Value (P/B)
¥2,323.52
-29.8%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=2853.45, ROE=8.7%, g=3%, r=10%
Reverse DCF
¥3,310.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 2.2% | Historical: -24.4%
Margin of Safety
¥2,343.10
-29.2%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=3124.13, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.